TAM
TARS icon

TFG Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

TFG Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-125,000
Closed -$7.43M – 42
2025
Q3 		$7.43M Sell
125,000
-125,000
-50% -$6.15M 0.99% 16
2025
Q2 		$10.1M Buy
250,000
+71,530
+40% +$3.22M 1.63% 13
2025
Q1 		$9.17M Sell
178,470
-21,530
-11% -$1.06M 2.09% 11
2024
Q4 		$11.1M Sell
200,000
-414,117
-67% -$18.8M 2.83% 12
2024
Q3 		$20.2M Buy
614,117
+114,117
+23% +$3.21M 5.7% 6
2024
Q2 		$13.6M Buy
500,000
+50,000
+11% +$1.68M 3.39% 11
2024
Q1 		$16.4M Sell
450,000
-350,000
-44% -$10.3M 3.71% 11
2023
Q4 		$16.2M Buy
800,000
+185,000
+30% +$3.09M 3.9% 13
2023
Q3 		$10.9M Buy
615,000
+450,000
+273% +$7.96M 1.99% 19
2023
Q2 		$2.98M Buy
+165,000
New +$2.62M 0.4% 32

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

TFG Asset Management's TARS Position: Q4 2025 in Review

TFG Asset Management sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 125,000 shares — an estimated $7.43M sold.

TFG Asset Management first reported a position in TARS in Q2 2023 and held it in 10 quarters. The position peaked at $20.2M in Q3 2024. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • TFG Asset Management reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • TFG Asset Management sold 125,000 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $7.43M.
  • TFG Asset Management first reported a position in Tarsus Pharmaceuticals in Q2 2023 and held it in 10 quarters.
  • TFG Asset Management's Tarsus Pharmaceuticals position peaked at $20.2M in Q3 2024.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on TFG Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.